Good Wednesday morning—here’s the straight-shooting rundown you need before markets open.
Market Pulse: Tech titan SpaceX ripped past Q3 expectations, sending shares skyward in after-hours trading, setting a bullish tone for the sector.
Key Movers: SpaceX’s earnings beat has traders buzzing about a potential short squeeze, while Netflix lived up to Q3 estimates but warned of a slowdown, and Indian PSU banks surged as private peers lagged.
Macro & Politics: The FDA’s twin approvals for Zilbrysq’s autoinjector and Haemonetics’ PerQseal® device highlight growing frustration over political red tape and its drag on innovation.
What’s Next: Eyes on Fed speakers today—any hawkish hints could keep bonds restless and equities volatile.
Market Commentary
Everyone’s overlooking the swelling short interest in SpaceX—sure, EPS hit $0.35 versus $0.13 as reported by Freerepublic.com, but if the bulls can’t lock up supply, this rocket run could stall when those shorts cover.
Tie that to the FDA’s slow-gear approvals featured in Medical Daily and PRNewswire: while biotech shares get windfalls, the same political bureaucracy throttles consumer-facing innovations—two halves of a system that rewards insiders and punishes disruption.
Here’s the tough call: trim exposure to names losing regulatory arbitrage and rotate into firms navigating political friction best—watch for breakout moves in companies with lean approval pipelines and minimal short interest.
📈 Breaking Financial News
Netflix Q3 Revenue Meets Wall Street Estimates, Forecasts Q4 Slowdown and Says It Will Miss Ad Sales Target for the Year
Netflix Q3 Revenue Meets Wall Street Estimates, Forecasts Q4 Slowdown and Says It Will Miss Ad Sales Target for the YearVariety Netflix posts third-quarter earnings beat, but shares fall on advertising and revenue guidanceCNBC Netflix Revenue Growth Slows as …
Zilbrysq Autoinjector Wins FDA Approval for Generalized Myasthenia Gravis, but Patients Must Wait Until Early 2027
FDA approved a once-daily Zilbrysq autoinjector for generalized myasthenia gravis. It launches in early 2027 with the same meningococcal infection warning.
Haemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure System
BOSTON, Oct. 19, 2026 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food and Drug Administration (FDA) approval of…
PSU bank stocks soar up to 8%, but HDFC, Axis and other private lenders fall up to 5% after Q2 results. Why the sharp divide?
PSU bank stocks surged up to 8% on Monday, led by Punjab National Bank after its Q2FY27 earnings beat estimates. In contrast, private lenders such as Axis Bank and HDFC Bank fell up to 5% despite reporting profit growth. The Nifty PSU Bank index gained over 2…
Here’s what happened in crypto today
Elon Musk thinks merging Tesla and SpaceX is a “good idea” now that SpaceX’s AI biz blew up ninefold, plotting a $3.5 trillion super-conglomerate even though he’s recused from the vote. Stablecoin transfers exploded to $891 billion … and after coughing up $388 million in a hack, Bitget is doubling down with a Thai exchange takeover.
Urgent warning for U.S. investors…
A major market shift could hit in days. Soaring stocks may crash, while overlooked ones surge. A secret signal-accurate since the Great Depression-is flashing again.
🔍 Market Analysis & Insights
Earnings call transcript: SpaceX tops Q3 2026 estimates, shares jump after hours
SpaceX reported a sharp beat for the third quarter of 2026, with earnings per share of $0.35 versus analyst expectations of $0.13 and revenue of $14.58 billion versus a forecast of $12.87 billion. The company also said net income reached $4.4 billion, reversi…
Earnings call transcript: SpaceX tops Q3 2026 estimates, shares jump after hours
SpaceX reported a sharp beat for the third quarter of 2026, with earnings per share of $0.35 versus analyst expectations of $0.13 and revenue of $14.58 billion versus a forecast of $12.87 billion. The company also said net income reached $4.4 billion, reversi…
SpaceX Live Q3 Earnings – Beat $14.6 billion Revenue, $4.4 Billion net Income
There will be 20 launch tower in Louisiana starting around 2029. They plan weekly Starship launches in the first half of 2026 and then twice weekly and then perhaps daily in 2027. This would be 100-200 launches in 2027. They will have 10Gw of AI data center a…
Netflix shares sink on earnings after a dramatic content executive shake-up
Netflix disappointed investors in its third-quarter earnings report. Investors have been worried about slowing engagement growth.
Banking stocks, high oil prices drag Indian markets lower
Across Asia, markets were mixed, with South Korea rebounding 1.8% from last week's losses amid simmering concerns over excessive investments in artificial intelligence (AI). Taiwan fell 0.6%, while Indonesia tumbled 3.6% following a warning from index provide…
This $5 Stock's Patented Tech Powers SpaceX's Most Profitable Division
Satellite constellations are worthless unless the data gets to the ground fast. Ross Givens says one tiny firm solved that physics problem — and is the only company that can supply the component at commercial scale. His new report is free for now.
💰 Investment Opportunities
Harnessing a Virus to Fight Brain Cancer: $2.5 Million NIH Award Advances Experimental Glioblastoma Therapy
At Rosalind Franklin University's Helix 51 biomedical incubator, an experimental Zika virus-based therapy for glioblastoma is moving closer to potential human clinical trials. NORTH CHICAGO, Ill., Oct. 19, 2026 /PRNewswire/ — A virus known for causingseriou…
Lumicell Appoints Marnie Curbow as Chief Executive Officer to Lead Company's Next Chapter of Growth and Innovation
WALTHAM, Mass., Oct. 19, 2026 /PRNewswire/ — Lumicell, Inc., a leader in fluorescence-guided imaging technology for cancer detection, today announced the promotion of Marnie Curbow to Chief Executive Officer, effective immediately. Curbow, who previously ser…
Readers Are Pleading To Make American Healthcare Greater
KFF Health News gives readers a chance to comment on a recent batch of stories.
Four Red Flags and One Truth Amid the Peptide Hype
Experimental peptides are all the rage on longevity and “optimization” podcasts, but a lot of the chatter is misleading.
TRT Is Becoming a Direct-to-Consumer Business, but Is That Wise?
Testosterone treatment has moved from the doctor's office to your doorstep. Citing industry market figures, Men's Fitness reports that the testosterone market has grown beyond $4 billion, while direct-to-consumer spending has surpassed $400 million.1 Today, y…
Buffett's Favorite Indicator Just Hit 231% – The Highest Level in History
It flashed the same warning before 1929, 1969 and 2000. Each time, gold ran for a decade while stocks went nowhere. Analyst Garrett Goggin explains what it signals now – and the four mining picks he's positioned in.